Baseline characteristics of the total study population and subdivided by postoperative complications
| Variable | Total (n=411) | With postoperative complications (n=32) | Without postoperative complications (n=379) |
| Demographics | |||
| Age (years) | 67±9 | 69±10 | 67±9 |
| Female sex (%) | 38 | 22 | 39 |
| Haemodynamic parameters | |||
| Systolic BP (mm Hg) | 143±21 | 137±21 | 144±21 |
| Diastolic BP (mm Hg) | 82±11 | 81±12 | 82±11 |
| LVEF (%) | 65±9 | 63±9 | 65±9 |
| Cardiovascular risk factors | |||
| Hypertension (%) | 100 | 100 | 100 |
| Current smoker (%) | 21 | 28 | 20 |
| BMI (kg/m2) | 27±4 | 28±5 | 27±4 |
| Laboratory values | |||
| SuPAR (ng/mL) | 2.6 (2.1, 3.3) | 3.0 (2.5, 3.9) | 2.6 (2.1, 3.2) |
| Glucose (mmol/L) | 5.2 (4.9, 5.6) | 5.3 (4.9, 6.0) | 5.2 (4.8, 5.6) |
| CRP (mg/L) | 2.4 (1.0, 4.9) | 1.9 (1.0, 5.5) | 2.5 (1.0, 4.9) |
| WBC (109/L) | 6.0±1.6 | 5.7±1.4 | 6.1±1.6 |
| Total cholesterol (mmol/L) | 5.7±1.0 | 5.3±0.8 | 5.8±1.0 |
| LDL (mmol/L) | 3.5±0.9 | 3.2±0.8 | 3.6±0.9 |
| HDL (mmol/L) | 1.6±0.4 | 1.5±0.4 | 1.6±0.4 |
| Triglycerides (mmol/L) | 1.2 (0.9, 1.7) | 1.2 (0.9, 1.4) | 1.2 (0.9, 1.7) |
| Creatinine (μmol/L) | 94±16 | 98±14 | 93±16 |
BMI, body mass index; BP, blood pressure; CRP, C-reactive protein; HDL, high-density lipoprotein; LDL, low-density lipoprotein; LVEF, left ventricular ejection fraction; suPAR, soluble urokinase plasminogen activator receptor; WBC, white blood cells.